Jupiter Research Capital (Asia) Ltd’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
SR
Jupiter Research Capital (Asia) Ltd's OCUL Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 22,374 shares worth $172K. The stake represents 0.02% of the portfolio and ranks #617 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in OCUL as recently as Q1 2026.
Jupiter Research Capital (Asia) Ltd first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. The position peaked at $243K in Q1 2026. 253 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 22,374 shares of Ocular Therapeutix worth $172K as of Q3 2026.
- Ocular Therapeutix was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Ocular Therapeutix made up 0.02% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #617 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
- Jupiter Research Capital (Asia) Ltd's Ocular Therapeutix position peaked at $243K in Q1 2026.
- 253 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.